| MIG | measles immune globulin; Medicare Insured Groups |
|---|---|
| MIg | malaria immunoglobulin; measles immunoglobulin; membrane immunoglobulin |
| MR | Maddox rods; magnetic resistance; magnetic resonance; mandibular reflex; mannose-resistant; may repe... |
| MRD | maximum rate of depolarization; measles-rindenpest-distemper [virus group]; medical records departme... |
| MV | measles virus; mechanical ventilation; megavolt; microvascular; microvillus; minute volume; mitral v... |
| haemorrhagic measles | <virology> Haemorrhagic measles is a severe type of measles where the little bumps are darkly coloured because blood has escaped into the skin. (09 Oct 1997) |
|---|---|
| human measles immune serum | Obtained from the blood of a healthy person who has survived an attack of measles. Synonym: measles convalescent serum. (05 Mar 2000) |
| immunization, german measles | See Immunization, MMR. (12 Dec 1998) |
| immunization, measles | See Immunization, MMR. (12 Dec 1998) |
| three-day measles | <disease, virology> An acute, usually benign, infectious disease caused by a togavirus and most often affecting children and nonimmune young adults, in which the virus enters the respiratory tract via droplet nuclei and spreads to the lymphatic system. It is characterised by a slight cold, sore throat and fever, followed by enlargement of the postauricular, suboccipital and cervical lymph nodes and the appearances of a fine pink rash that begins on the head and spreads to become generalised. Synonym: German measles, rubeola. Origin: L. Rubellus = reddish, ruber = red (17 Dec 1997) |
| tropical measles | <infectious disease, virology> A disease of uncertain character, somewhat resembling rubella, occurring in southern China. (05 Mar 2000) |
| acellular vaccine | <immunology, pharmacology, virology> Vaccine consisting of antigenic parts of cells. (13 Nov 1997) |
| adjuvant vaccine | A vaccine that contains an adjuvant; most often the antigen (immunogen) is included in a water-in-oil emulsion (Freund incomplete type adjuvant), or is adsorbed onto an inorganic gel (alum, aluminum hydroxide or phosphate). (05 Mar 2000) |
| aqueous vaccine | A vaccine having a liquid vehicle (e.g., physiological salt solution) as distinguished from an emulsion. (05 Mar 2000) |
| attenuated vaccine | Live pathogens that have lost their virulence but are still capable of inducing a protective immune response to the virulent forms of the pathogen, e.g., Sabin polio vaccine. (05 Mar 2000) |
| autogenous vaccine | A vaccine made from a culture of the patient's own bacteria. (05 Mar 2000) |
| bacillus Calmette-Guerin vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| BCG vaccine | <drug> Live attenuated vaccine for tuberculosis. For groups and health care workers in high endemic areas. Not to be given to individuals with HIV infection. (15 Nov 1997) |
| brucella strain 19 vaccine | A live bacterial vaccine prepared from an attenuated variant strain of Brucella abortus (strain 19); used for vaccinating cattle against brucellosis. (05 Mar 2000) |
| brucella vaccine | A bacterial vaccine for the prevention of brucellosis in man and animal. Brucella abortus vaccine is used for the immunization of cattle, sheep, and goats. (12 Dec 1998) |